Different Effects of Absorption Promoters on Corneal and Conjunctival Penetration of Ophthalmic Beta-Blockers

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Pharmaceutical Research

• Publication date

  1995-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1023/A:1016203725128PMID 7494826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Penetration of β‐Blockers through Ocular Membranes in A1bino Rabbits

  1995cited by this paper
• Mechanisms of absorption enhancement and tight junction regulation

  1994cited by this paper
• Drug release from an ophthalmic insert of a beta-blocker as an ocular drug delivery system

  1993cited by this paper
• Ocular delivery of the β-blocker, tilisolol, through the prodrug approach

  1993cited by this paper
• Conjunctival Penetration of Insulin and Peptide Drugs in the Albino Rabbit

  1992cited by this paper
• Formulation Influence on Conjunctival Penetration of Four Beta Blockers in the Pigmented Rabbit: A Comparison with Corneal Penetration

  1991cited by this paper
• Paracellular permeability of corneal and conjunctival epithelia.

  1989cited by this paper
• In vitro study on corneal permeability to bunazosin.

  1988cited by this paper
• Topically applied cyclosporine in azone prolongs corneal allograft survival.

  1988cited by this paper
• Ophthalmic beta-blockers since timolol.

  1987cited by this paper
• Topical Ocular Drug Delivery: Recent Developments and Future Challenges

  1986cited by this paper
• Corneal Penetration Behavior of β-Blocking Agents I: Physicochemical Factors

  1983cited by this paper
• Corneal penetration behavior of beta-blocking agents I: Physiochemical factors.

  1983cited by this paper
• Biophasic availability of ophthalmic carbachol. I. Mechanisms of cationic polymer- and surfactant-promoted miotic activity.

  1973cited by this paper
• METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES

  1944cited by this paper

• Topical Ocular Drug Delivery: The Impact of Permeation Enhancers

  2025cites this paper
• Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles

  2020cites this paper
• Recent Advances in Nano-Formulations for Ophthalmic Drug Delivery

  2020cites this paper
• Development of acetazolamide loaded bilosomes for improved ocular delivery: Preparation, characterization and in vivo evaluation

  2020cites this paper
• Bio-friendly encapsulation of superoxide dismutase into vaterite CaCO3 crystals. Enzyme activity, release mechanism, and perspectives for ophthalmology.

  2019cites this paper
• Penetration Enhancers in Ocular Drug Delivery

  2019cites this paper
• The Inclusion of Timolol and Lisinopril in Calcium Phosphate Particles Covered by Chitosan: Application in Ophthalmology

  2018cites this paper
• A novel ion-activated in situ gelling ophthalmic delivery system based on κ-carrageenan for acyclovir

  2018cites this paper
• Sodium perbarate and benzalkonium chloride induce DNA damage in Chang conjunctival epithelial cells

  2017cites this paper
• Nanoparticles for drug delivery to the anterior segment of the eye.

  2017cites this paper
• Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate

  2017cites this paper
• Biodegradable Polymeric Biomaterials in Different Forms for Long-acting Contraception and Drug Delivery to the Eye and Brain

  2017cites this paper
• In vitro characterization & Pharmacokinetic evaluation of ion activated in situ gelling system for Betaxolol Hydrochloride

  2017cites this paper
• DRUG DELIVERY ENHANCEMENT STRATEGIES THROUGH CORNEA: A REVIEW

  2016cites this paper
• A review on “in situ gel-forming system: an attractive alternative for improvement of bioavailability’’

  2016cites this paper
• Understanding the influence of surface properties of nanoparticles and penetration enhancers for improving bioavailability in eye tissues in vivo.

  2016cites this paper
• In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects

  2016cites this paper
• Barriers to Glaucoma Drug Delivery and Resolving the Challenges Using Nanotechnology

  2016cites this paper
• Formulation Approaches for Ocular Drug Delivery

  2016cites this paper
• Mucoadhesive polymers in ophthalmic therapy

  2015cites this paper
• Intravitreal injection of connexin43 mimetic peptides for the treatment of optic neuropathy using an in vivo retinal ischaemia-reperfusion rat model

  2014cites this paper
• Development and evaluation of in situ gelling system for treatment of periodontitis

  2014cites this paper
• Ultrasound-enhanced ocular delivery of dexamethasone sodium phosphate: an in vivo study

  2014cites this paper
• Ocular Delivery of Biopharmaceuticals

  2014cites this paper
• Ultrasound-enhanced delivery of antibiotics and anti-inflammatory drugs into the eye.

  2013cites this paper
• Recent advances in ocular drug delivery

  2013cites this paper
• Novel Polymeric in Situ Gels for Ophthalmic Drug Delivery System

  2012cites this paper
• High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells

  2012cites this paper
• Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells

  2012cites this paper
• Transcorneal Permeation of Ciprofloxacin Liposomes: Effect of Surface Charge and Nonionic Surfactants

  2011cites this paper
• Ocular Drug Delivery

  2010cites this paper
• Evaluation of Acute Corneal Barrier Change Induced by Topically Applied Preservatives Using Corneal Transepithelial Electric Resistance In Vivo

  2010cites this paper
• Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis

  2009cites this paper
• Barriers to Glaucoma Drug Delivery

  2008cites this paper
• Acute Corneal Epithelial Change after Instillation of Benzalkonium Chloride Evaluated Using a Newly Developed in vivo Corneal Transepithelial Electric Resistance Measurement Method

  2007cites this paper
• Ability of poly-L-arginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits.

  2007cites this paper
• Antibodies and their fragments as anti-cancer agents.

  2006cites this paper
• AWARD NUMBER: DAMD17-02-1-0661 TITLE: Analysis of Microtubule Mediated Functions of Prostate Specific Membrane Antigen

  2006cites this paper
• Ocular drug delivery

  2006cites this paper
• Environmentally Responsive Ophthalmic Gel Formulation of Carteolol Hydrochloride

  2006influential citation
• Topically applied antibody fragments penetrate into the back of the rabbit eye

  2005cites this paper
• Synergistic effect of EDTA and boric acid on corneal penetration of CS-088.

  2005cites this paper
• Effect of benzalkonium chloride on transscleral drug delivery.

  2005cites this paper
• Biological impediments to monoclonal antibody-based cancer immunotherapy.

  2004cites this paper
• A Study of the Role of Therapeutic Contact Lenses in Drug Delivery

  2004cites this paper
• EDTA enhances the antitumor efficacy of intratumoral cisplatin in s.c. grafted rat colon tumors

  2004cites this paper
• Improvement of the ocular bioavailability of timolol by sorbic acid.

  2004cites this paper
• Ocular Tissue Permeabilities

  2004cites this paper
• Drug Delivery Into the Eye With the Use of Ultrasound

  2004cites this paper
• Development of Cultured Rabbit Corneal Epithelium for Drug Permeation Studies: A Comparison with Excised Rabbit Cornea

  2004cites this paper
• Influence of Hydroxypropyl β-Cyclodextrin on the Corneal Permeation of Pilocarpine

  2003cites this paper
• Ocular Preparations: The Formulation Approach

  2002cites this paper
• Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery

  2002cites this paper
• Ocular drug delivery using 20-kHz ultrasound.

  2002cites this paper
• Ocular tolerance of absorption enhancers in ophthalmic preparations

  2002cites this paper
• Penetration of engineered antibody fragments into the eye

  2002cites this paper
• [Development of an organotypic corneal construction as an in vitro model for permeability studies].

  2001cites this paper
• The effect of absorption enhancers on the initial degradation kinetics of insulin by alpha-chymotrypsin.

  2001cites this paper
• Enhancement of ocular drug penetration.

  1999cites this paper
• The influence of penetration enhancers on the volume instilled of eye drops.

  1998cites this paper
• Biopharmaceutical availability of sulphadicramide from ocular ointments in vitro.

  1998cites this paper
• Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.

  1997cites this paper
• A REVIEW ON: PENETRATION ENHANCERS FOR OCULAR DRUG DELIVERY

  year unknowncites this paper